The company reported a net loss in 2025 of $3,600,000 as compared to a net loss of $1,500,000 in the prior year's third ...

As North America CEO of one of the world’s largest communications agencies, Jim O’Leary was used to clients asking him how AI ...

Vir Biotechnology, Inc. today announced that Week 48 endpoint analysis from the Company's Phase 2 SOLSTICE trial for chronic hepatitis delta (CHD) demonstrated that participants receiving a monthly ...